13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001398344-26-002970
Total Value
$1.5M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $630,000 | 43.36% |
| 2 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $449,607 | 30.95% |
| 3 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $373,196 | 25.69% |